Skip to content
December 18, 2024

Assessment of Uveal Melanoma Using Machine Learnin...

Michael Heiferman’s Abstract Uveal Melanoma (UM), a deadly cancer arising in the eye, is the most common eye cancer in adults. Early detection of UM is important due ...

3 Minute Read
December 18, 2024

ADAR1 Inhibitor: Novel Therapeutic for Melanoma &a...

Kazuko Nishikura’s Abstract The phenomenon of “RNA editing” is a relatively recent discovery with exciting implications. RNA editing is a process that modifies th...

3 Minute Read
December 18, 2024

Targeting PCBP2 to augment melanoma cell killing b...

Korbinian Kropp’s Abstract A major reason that T cell-based melanoma immunotherapies can fail, either initially or after a period of treatment, is due to mutations th...

2 Minute Read
December 18, 2024

Engaging the endogenous immune system with CAR T c...

Sarwish Rafiq’s Abstract Metastatic melanoma is one of the most aggressive, and complex cancers with a 35% 5-year survival rate. Therapies using T cells that are gene...

1 Minute Read
December 18, 2024

Complex Genomic Rearrangements Driving Sub-Clonal ...

Prashanthi Dharanipragada’s Abstract For decades, cancer initiation and progression are thought to occur gradually through small mutational changes in its DNA. After ...

2 Minute Read
December 18, 2024

Neoadjuvant immunotherapy and radiotherapy for muc...

Devarati Mitra’s Abstract Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactor...

1 Minute Read
February 24, 2024

SMR Young Investigator Award

SMR Young Investigator Award – Vito Rebecca, PhD

1 Minute Read

Feb 08, 2026 ET

Miami Miles for Melanoma 5K

Feb 22, 2026 ET

Orange County Miles for Melanoma 5K

Mar 01, 2026 ET - Mar 03, 2026

2026 Advocacy Days

Apr 17, 2026 ET - Apr 19, 2026

2026 Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

Explore Events